Cardiac magnetic resonance in patients with ARVC and family members: the potential role of native T1 mapping
2021-01-01 Georgiopoulos, G.; Zampieri, M.; Molaro, S.; Chaloupka, A.; Aimo, A.; Barra, B.; Roberts, L.; Monje-Garcia, L.; Evans, C.; Sheikh, N.; Bastiaenen, R.; Cooklin, M.; Masci, P. -G.; Carr-White, G.; Finocchiaro, G.; Chiribiri, A.
Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences
2021-01-01 Aimo, A.
Myocardial perfusion years after radiation therapy for left-sided breast cancer: Normal or abnormal? This is the question
2019-01-01 Aimo, A.; Gimelli, A.
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis
2021-01-01 Pucci, A.; Aimo, A.; Musetti, V.; Barison, A.; Vergaro, G.; Genovesi, D.; Giorgetti, A.; Masotti, S.; Arzilli, C.; Prontera, C.; Pastormerlo, L. E.; Coceani, M. A.; Ciardetti, M.; Martini, N.; Palmieri, C.; Passino, C.; Rapezzi, C.; Emdin, M.
Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’
2020-01-01 Aimo, A.; Castiglione, V.; Lombardi, C. M.
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
2021-01-01 Fabiani, I.; Aimo, A.; Grigoratos, C.; Castiglione, V.; Gentile, F.; Saccaro, L. F.; Arzilli, C.; Cardinale, D.; Passino, C.; Emdin, M.
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
2021-01-01 Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure
2021-01-01 Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides
2021-01-01 Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C.
Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine?
2021-01-01 Barison, A.; Aimo, A.
Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
2020-01-01 Aimo, A.; de Caterina, R.
Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction
2021-01-01 Gimelli, A.; Aimo, A.; Pasanisi, E. M.; Coceani, M. A.; Clemente, A.; Emdin, M.; Shaw, L. J.
The Relativity of Reference Values for Myocardial Perfusion Imaging
2021-01-01 Gimelli, A.; Aimo, A.
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis
2020-01-01 Figliozzi, S.; Masci, P. G.; Ahmadi, N.; Tondi, L.; Koutli, E.; Aimo, A.; Stamatelopoulos, K.; Dimopoulos, M. -A.; Caforio, A. L. P.; Georgiopoulos, G.
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
2021-01-01 Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M.
COVID-19 and myocarditis: a systematic review and overview of current challenges
2021-01-01 Castiello, T.; Georgiopoulos, G.; Finocchiaro, G.; Claudia, M.; Gianatti, A.; Delialis, D.; Aimo, A.; Prasad, S.
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences
2021-01-01 Saccaro, L. F.; Aimo, A.; Emdin, M.; Pico, F.
High-sensitivity cardiac troponins in pediatric population
2021-01-01 Clerico, A.; Aimo, A.; Cantinotti, M.
Response to the comment by Dr Yarlas
2021-01-01 Aimo, A.
Pirfenidone as a novel cardiac protective treatment
2021-01-01 Aimo, A.; Spitaleri, G.; Panichella, G.; Lupon, J.; Emdin, M.; Bayes-Genis, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cardiac magnetic resonance in patients with ARVC and family members: the potential role of native T1 mapping | 1-gen-2021 | Georgiopoulos, G.; Zampieri, M.; Molaro, S.; Chaloupka, A.; Aimo, A.; Barra, B.; Roberts, L.; Monje-Garcia, L.; Evans, C.; Sheikh, N.; Bastiaenen, R.; Cooklin, M.; Masci, P. -G.; Carr-White, G.; Finocchiaro, G.; Chiribiri, A. | |
| Longitudinal changes in cardiac biomarkers and outcome in heart failure: Sex-related differences | 1-gen-2021 | Aimo, A. | |
| Myocardial perfusion years after radiation therapy for left-sided breast cancer: Normal or abnormal? This is the question | 1-gen-2019 | Aimo, A.; Gimelli, A. | |
| Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis | 1-gen-2021 | Pucci, A.; Aimo, A.; Musetti, V.; Barison, A.; Vergaro, G.; Genovesi, D.; Giorgetti, A.; Masotti, S.; Arzilli, C.; Prontera, C.; Pastormerlo, L. E.; Coceani, M. A.; Ciardetti, M.; Martini, N.; Palmieri, C.; Passino, C.; Rapezzi, C.; Emdin, M. | |
| Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Letter regarding the article ‘Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial’ | 1-gen-2020 | Aimo, A.; Castiglione, V.; Lombardi, C. M. | |
| Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets | 1-gen-2021 | Fabiani, I.; Aimo, A.; Grigoratos, C.; Castiglione, V.; Gentile, F.; Saccaro, L. F.; Arzilli, C.; Cardinale, D.; Passino, C.; Emdin, M. | |
| Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient | 1-gen-2021 | Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M. | |
| Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure | 1-gen-2021 | Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C. | |
| Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides | 1-gen-2021 | Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C. | |
| Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine? | 1-gen-2021 | Barison, A.; Aimo, A. | |
| Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification | 1-gen-2020 | Aimo, A.; de Caterina, R. | |
| Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction | 1-gen-2021 | Gimelli, A.; Aimo, A.; Pasanisi, E. M.; Coceani, M. A.; Clemente, A.; Emdin, M.; Shaw, L. J. | |
| The Relativity of Reference Values for Myocardial Perfusion Imaging | 1-gen-2021 | Gimelli, A.; Aimo, A. | |
| Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis | 1-gen-2020 | Figliozzi, S.; Masci, P. G.; Ahmadi, N.; Tondi, L.; Koutli, E.; Aimo, A.; Stamatelopoulos, K.; Dimopoulos, M. -A.; Caforio, A. L. P.; Georgiopoulos, G. | |
| The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction | 1-gen-2021 | Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M. | |
| COVID-19 and myocarditis: a systematic review and overview of current challenges | 1-gen-2021 | Castiello, T.; Georgiopoulos, G.; Finocchiaro, G.; Claudia, M.; Gianatti, A.; Delialis, D.; Aimo, A.; Prasad, S. | |
| Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences | 1-gen-2021 | Saccaro, L. F.; Aimo, A.; Emdin, M.; Pico, F. | |
| High-sensitivity cardiac troponins in pediatric population | 1-gen-2021 | Clerico, A.; Aimo, A.; Cantinotti, M. | |
| Response to the comment by Dr Yarlas | 1-gen-2021 | Aimo, A. | |
| Pirfenidone as a novel cardiac protective treatment | 1-gen-2021 | Aimo, A.; Spitaleri, G.; Panichella, G.; Lupon, J.; Emdin, M.; Bayes-Genis, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista13785
Data di pubblicazione
- In corso di stampa43
- 2020 - 20265041
- 2010 - 20195528
- 2000 - 20092309
- 1990 - 1999608
- 1980 - 1989211
- 1970 - 197945
Editore
- IEEE / Institute of Electrical an...55
- Elsevier BV:PO Box 211, 1000 AE A...27
- Springer-Verlag New York Incorpor...23
- Il Sole 24 Ore Edagricole:via Goi...22
- Springer Verlag Germany:Tiergarte...18
- Informatore Agrario SRL:Largo Cal...17
- Oxford University Press:Journals ...12
- American Physiological Society:96...11
- Firenze: Società orticola italiana.11
- Giuffre Editore Spa:via Busto Ars...11
Rivista
- JOURNAL OF LIGHTWAVE TECHNOLOGY182
- IEEE PHOTONICS TECHNOLOGY LETTERS140
- SCIENTIFIC REPORTS104
- INTERNATIONAL JOURNAL OF CARDIOLOGY102
- SENSORS90
- OPTICS EXPRESS82
- JOURNAL OF OPTICAL COMMUNICATIONS...78
- ACTA HORTICULTURAE77
- IEEE TRANSACTIONS ON NEURAL SYSTE...69
- OPTICS LETTERS69
Keyword
- Humans334
- Male153
- Female137
- Electrical and Electronic Enginee...127
- and Optics123
- Atomic and Molecular Physics123
- Heart failure121
- Italy90
- Prognosis90
- Cardiology and Cardiovascular Med...85
Lingua
- eng11015
- ita2610
- spa72
- fre38
- ger19
- por15
- tur11
- rus7
- und7
- chi6
Accesso al fulltext
- no fulltext7140
- open3961
- reserved1572
- restricted1063
- embargoed37
- partially open12